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Abstract: In genetic studies of complex diseases, the underlying mode of in-
heritance is often not known. Thus, the most powerful test or other optimal
procedure for one model, e.g. recessive, may be quite inefficient if another
model, e.g. dominant, describes the inheritance process. Rather than choose
among the procedures that are optimal for a particular model, it is preferable
to see a method that has high efficiency across a family of scientifically realis-
tic models. Statisticians well recognize that this situation is analogous to the
selection of an estimator of location when the form of the underlying distribu-
tion is not known. We review how the concepts and techniques in the efficiency
robustness literature that are used to obtain efficiency robust estimators and
rank tests can be adapted for the analysis of genetic data. In particular, several
statistics have been used to test for a genetic association between a disease and
a candidate allele or marker allele from data collected in case-control studies.
Each of them is optimal for a specific inheritance model and we describe and
compare several robust methods. The most suitable robust test depends some-
what on the range of plausible genetic models. When little is known about
the inheritance process, the maximum of the optimal statistics for the extreme
models and an intermediate one is usually the preferred choice. Sometimes one
can eliminate a mode of inheritance, e.g. from prior studies of family pedigrees
one may know whether the disease skips generations or not. If it does, the
disease is much more likely to follow a recessive model than a dominant one.
In that case, a simpler linear combination of the optimal tests for the extreme
models can be a robust choice.
1. Introduction
For hypothesis testing problems when the model generating the data is known,
optimal test statistics can be derived. In practice, however, the precise form of the
underlying model is often unknown. Based on prior scientific knowledge a family
of possible models is often available. For each model in the family an optimal
test statistic is obtained. Hence, we have a collection of optimal test statistics
corresponding to each member of the family of scientifically plausible models and
need to select one statistic from them or create a robust one, that combines them.
Since using any single optimal test in the collection typically results in a substantial
loss of efficiency or power when another model is the true one, a robust procedure
with reasonable power over the entire family is preferable in practice.
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The above situation occurs in many applications. For example, in survival anal-
ysis Harrington and Fleming [14] introduced a family of statistics Gρ. The family
includes the log-rank test (ρ = 0) that is optimal under the proportional hazards
model and the Peto-Peto test (ρ = 1, corresponding to the Wilcoxon test without
censoring) that is optimal under a logistic shift model. In practice, when the model
is unknown, one may apply both tests to survival data. It is difficult to draw scien-
tific conclusions when one of the tests is significant and the other is not. Choosing
the significant test after one has applied both tests to the data increases the Type
I error. A second example is testing for an association between a disease and a risk
factor in contingency tables. If the risk factor is a categorical variable and has a
natural order, e.g., number of packs of cigarette smoking per day, the Cochran-
Armitage trend test is typically used. (Cochran [3] and Armitage [1]) To apply
such a trend test, increasing scores as values of a covariate have to be assigned to
each category of the risk factor. Thus, the p-value of the trend test may depend
on such scores. A collection of trend tests is formed by choosing various increasing
scores. (Graubard and Korn [12]) A third example arises in genetic linkage and
association studies. In linkage analysis to map quantitative trait loci using affected
sib pairs, optimal tests are functions of the number of alleles shared identical-by-
descent (IBD) by the two sibs. The IBD probabilities form a family of alternatives
which are determined by genetic models. See, e.g., Whittemore and Tu [22] and
Gastwirth and Freidlin [10]. In genetic association studies using case-parents trios,
the optimal test depends on the mode of inheritance of the disease (recessive, dom-
inant, or co-dominant disease). For complex diseases, the underlying genetic model
is often not known. Using a single optimal test does not protect against a sub-
stantial loss of power under the worst situation, i.e., when a much different genetic
model is the true one. (Zheng, Freidlin and Gastwirth [25])
Robust procedures have been developed and applied when the underlying model
is unknown as discussed in Gastwirth [7, 8, 9], Birnbaum and Laska [2], Podgor,
Gastwirth and Mehta [16], and Freidlin, Podgor and Gastwirth [5]. In this article,
we review two useful robust tests. The first one is a linear combination of the two or
three extreme optimal tests in a family of optimal statistics and the second one is
a suitably chosen maximum statistic, i.e., the maximum of several of the optimum
tests for specific models in the family. These two robust procedures are applied to
genetic association using case-control studies and compared to other test statistics
that are used in practice.
2. Robust procedures: A short review
Suppose we have a collection of alternative models {Mi, i ∈ I} and the correspond-
ing optimal (most powerful) test statistics {Ti : i ∈ I} are obtained, where I can be
a finite set or an interval. Under the null hypothesis, assume that each of these test
statistics is asymptotically normally distributed, i.e., Zi = [Ti−E(Ti)]/{Var(Ti)}
1/2
converges in law to N(0, 1) where E(Ti) and Var(Ti) are the mean and the variance
of Ti under the null; suppose also that for any i, j ∈ I, Zi and Zj are jointly normal
with the correlation ρij . When Mi is the true model, the optimal test Zi would
be used. When the true model Mi is unknown and the test Zj is used, assume the
Pitman asymptotic relative efficiency (ARE) of Zj relative to Zi is e(Zj, Zi) = ρ
2
ij
for i, j ∈ I. These conditions are satisfied in many applications. (van Eeden [21]
and Gross [13])
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2.1. Maximin efficiency robust tests
When the true model is unknown and each model in the family is scientifically
plausible, the minimum ARE compared to the optimum test for each model, Zi,
when Zj is used is given by infi∈I e(Zj , Zi) for j ∈ I. One robust test is to choose
the optimal test Zl from the family {Zi : i ∈ I} which maximizes the minimum
ARE, that is,
(2.1) inf
i∈I
e(Zl, Zi) = sup
j∈I
inf
i∈I
e(Zj , Zi).
Under the null hypothesis, Zl converges in distribution to a standard normal random
variable and, under the definition (2.1), is the most robust test in {Zi : i ∈ I}. In
practice, however, other tests have been studied which may have greater efficiency
robustness.
Although a family of models are proposed based on scientific knowledge and the
corresponding optimal tests can be obtained, all consistent tests with an asymptot-
ically normal distribution can be used. Denote all these tests for the problem by C.
The original family of test statistics can be expanded to C. The purpose is to find
a test Z from C, rather than from the original family {Zi : i ∈ I}, such that
(2.2) inf
i∈I
e(Z,Zi) = sup
Z∈C
inf
i∈I
e(Z,Zi).
The test Z satisfying (2.2) is called maximin efficiency robust test (MERT). (Gast-
wirth [7]) When the family C is restricted to the convex linear combinations of
{Zi : i ∈ I}, the resulting robust test is denoted as ZMERT. Since {Zi : i ∈ I} ⊂ C,
sup
Z∈C
inf
i∈i
e(Z,Zi) ≥ sup
j∈I
inf
i∈I
e(Zj , Zi).
Assuming that infi,j∈I ρij ≥ ǫ > 0, Gastwirth [7] proved that ZMERT uniquely
exists and can be written as a closed convex combination of optimal tests Zi in
the family {Zi : i ∈ i}. Although a simple algorithm when C is the class of linear
combination of {Zi : i ∈ I} was given in Gastwirth [9] (see also Zucker and Lakatos
[27]), the computation of ZMERT is more complicated as it is related to quadratic
programming algorithms. (Rosen [18]) For many applications, ZMERT can be easily
written as a linear convex combination of two or three optimal tests in {Zi : i ∈ I}
including the extreme pair defined as follows: two optimal tests Zs, Zt ∈ {Zi : i ∈ I}
are called extreme pair if ρst = corrH0(Zs, Zt) = infi,j∈I ρij > 0. Define a new test
statistic Zst based on the extreme pair as
(2.3) Zst =
Zs + Zt
[2(1 + ρst)]1/2
,
which is the MERT for the extreme pair. A necessary and sufficient condition for
Zst to be ZMERT for the whole family {Zi : i ∈ I} is given, see Gastwirth [8], by
(2.4) ρsi + ρit ≥ 1 + ρst, for all i ∈ I.
Under the null hypothesis, ZMERT is asymptoticallyN(0, 1). The ARE of the MERT
given by (2.4) is (1 + ρst)/2. To find the MERT, the null correlations ρij need to
be obtained and the pair is the extreme pair for which ρij is smallest.
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2.2. Maximum tests
The robust test ZMERT is a linear combination of the optimal test statistics and
with modern computers it is useful to extend the family C of possible tests to
include non-linear functions of the Zi. A natural non-linear robust statistic is the
maximum over the extreme pair (Zs, Zt) or the triple (Zs, Zu, Zt) for the entire
family (Freidlin et al. [5]), i.e.,
ZMAX2 = max(Zs, Zt) or ZMAX3 = max(Zs, Zu, Zt).
There are several choices for Zu in ZMAX3, e.g., Zu = Zst (MERT for the extreme
pair or entire family). As when obtaining the MERT, the correlation matrix {ρij}
guides the choice of Zu to be used in MAX3, e.g., it has equal correlation with the
extreme tests. A more complicated maximum test statistic is to take the maximum
over the entire family ZMAX = maxi∈I Zi or ZMAX = maxi∈C Zi. ZMAX was con-
sidered by Davies [4] for some non-standard hypothesis testing whose critical value
has to be determined by approximation of its upper bound. In a recent study of
several applications in genetic association and linkage analysis, Zheng and Chen
[24] showed that ZMAX3 and ZMAX have similar power performance in these ap-
plications. Moreover, ZMAX2 or ZMAX3 are much easier to compute than ZMAX.
Hence, in the next section, we only consider the two maximum tests ZMAX2 and
ZMAX3. The critical values for the maximum test statistics can be found by simula-
tion under the null hypothesis as any two or three optimal statistics in {Zi : i ∈ I}
follow multivariate normal distributions with correlation matrix {ρij}. For exam-
ple, given the data, ρst can be calculated. Generating a bivariate normal random
variable (Zsj , Ztj) with the correlation matrix {pst} for j = 1, . . . , B. For each j,
ZMAX2 is obtained. Then an empirical distribution for ZMAX2 can be obtained
using these B simulated maximum statistics, from which we can find the critical
values. In some applications, if the null hypothesis does not depend on any nuisance
parameters, the distribution of ZMAX2 or ZMAX3 can be simulated exactly without
the correlation matrix, e.g., Zheng and Chen [24].
2.3. Comparison of MERT and MAX
Usually, ZMERT is easier to compute and use than ZMAX2 (or ZMAX3). Intuitively,
however, ZMAX3 should have greater efficiency robustness than ZMERT when the
range of models is wide. The selection of the robust test depends on the minimum
correlation ρst of the entire family of optimal tests. Results from Freidlin et al. [5]
showed that when ρst ≥ 0.75, MERT and MAX2 (MAX3) have similar power; thus,
the simpler MERT can be used. For example, when ρst = 0.75, the ARE of MERT
relative to the optimal test for any model in the family is at least 0.875. When
ρst < 0.50, MAX2 (MAX3) is noticeably more powerful than the simple MERT.
Hence, MAX2 (MAX3) is recommended. For example, in genetic linkage analysis
using affected sib pairs, the minimum correlation is greater than 0.8, and the MERT,
MAX2, and MAX3 have similar power. (Whittemore and Tu [22] and Gastwirth
and Freidlin [10]) For analysis of case-parents data in genetic association studies
where the mode of inheritance can range from pure recessive to pure dominant,
the minimum correlation is less than 0.33, and then the MAX3 has desirable power
robustness for this problem. (Zheng et al. [25])
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3. Genetic association using case-control studies
3.1. Background
It is well known that association studies testing linkage disequilibrium are more
powerful than linkage analysis to detect small genetic effects on traits. (Risch and
Merikangas [17]) Moreover association studies using cases and controls are easier
to conduct as parental genotypes are not required.
Assume that cases are sampled from the study population and that controls
are independently sampled from the general population without disease. Cases and
controls are not matched. Each individual is genotyped with one of three genotypes
MM , MN and NN for a marker with two alleles M and N . The data obtained
in case-control studies can be displayed as in Table 1 (genotype-based) or as in
Table 2 (allele-based).
Define three penetrances as f0 = Pr(case|NN), f1 = Pr(case|NM), and f2 =
Pr(case|MM), which are the disease probabilities given different genotypes. The
prevalence of disease is denoted as D = Pr(case). The probabilities for genotypes
(NN,NM,MM) in cases and controls are denoted by (p0, p1, p2) and (q0, q1, q2),
respectively. The probabilities for genotypes (NN,NM,MM) in the general pop-
ulation are denoted as (g0, g1, g2). The following relations can be obtained.
(3.1) pi =
figi
D
and qi =
(1− fi)gi
1−D
for i = 0, 1, 2.
Note that, in Table 1, (r0, r1, r2) and (s0, s1, s2) follow multinomial distributions
mul(R; p0, p1, p2) and mul(S; q0, q1, q2), respectively. Under the null hypothesis of
no association between the disease and the marker, pi = qi = gi for i = 0, 1, 2.
Hence, from (3.1), the null hypothesis for Table 1 is equivalent to H0 : f0 = f1 =
f2 = D. Under the alternative, penetrances are different as one of two alleles is a
risk allele, say, M . In genetic analysis, three genetic models (mode of inheritance)
are often used. A model is recessive (rec) when f0 = f1, additive (add) when f1 =
(f0+f2)/2, and dominant (dom) when f1 = f2. For recessive and dominant models,
the number of columns in Table 1 can be reduced. Indeed, the columns with NN
and NM (NM andMM) can be collapsed for recessive (dominant) model. Testing
association using Table 2 is simpler but Sasieni [19] showed that genotype based
analysis is preferable unless cases and controls are in Hardy–Weinberg Equilibrium.
Table 1
Genotype distribution for case-control studies
NN NM MM Total
Case r0 r1 r2 r
Control s0 s1 s2 s
Total n0 n1 n2 n
Table 2
Allele distribution for case-control studies
N M Total
Case 2r0 + r1 r1 + 2r2 2r
Control 2s0 + s1 s1 + 2s2 2s
Total 2n0 + n1 n1 + 2n2 2n
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3.2. Test statistics
For the 2× 3 table (Table 1), a chi-squared test with 2 degrees of freedom (df) can
be used. (Gibson and Muse [11]) This test is independent of the underlying genetic
model. Note that, under the alternative when M is the risk allele, the penetrances
have a natural order: f0 ≤ f1 ≤ f2 (at least one inequality hold). The Cochran-
Armitage (CA) trend test (Cochran [3] and Armitage [1]) taking into account the
natural order should be more powerful than the chi-squared test as the trend test
has 1 df.
The CA trend test can be obtained as a score test under the logistic regression
model with genotype as a covariate, which is coded using scores x = (x0, x1, x1) for
(NN,NM,MM), where x0 ≤ x1 ≤ x2. The trend test can be written as (Sasieni
[19])
Zx =
n1/2
∑2
i=0 xi(sri − rsi)
{rs[n
∑2
i=0 x
2
ini − (
∑2
i=0 xini)
2]}1/2
.
Since the trend test is invariant to linear transformations of x, without loss of
generality, we use the scores x = (0, x, 1) with 0 ≤ x ≤ 1 and denote Zx as Zx.
Under the null hypothesis, Zx has an asymptotic normal distribution N(0, 1). When
M is a risk allele, a one-sided test is used. Otherwise, a two-sided test should be used.
Results from Sasieni [19] and Zheng, Freidlin, Li and Gastwirth [26] showed that the
optimal choices of x for recessive, additive and dominant models are x = 0, x = 1/2,
and x = 1, respectively. That is, Z0, Z1/2 or Z1 is an asymptotically most powerful
test when the genetic model is recessive, additive or dominant. The tests using
other values of x are optimal for penetrances in the range 0 < f0 ≤ f1 ≤ f2 < 1.
For complex diseases, the genetic model is not known a priori. The optimal
test Zx cannot be used directly as a substantial loss of power may occur when x
is misspecified. Applying the robust procedures introduced in Section 2, we have
three genetic models and the collection of all consistent tests C = {Zx : x ∈ [0, 1]}.
To find a robust test, we need to evaluate the null correlations. Denote these as
corrH0(Zx1 , Zx2) = ρx1,x2 . From appendix C of Freidlin, Zheng, Li and Gastwirth
[6],
ρ0,1/2 =
p0(p1 + 2p2)
{p0(1 − p0)}1/2{(p1 + 2p2)p0 + (p1 + 2p0)p2}1/2
,
ρ0,1 =
p0p2
{p0(1 − p0)}1/2{p2(1 − p2)}1/2
,
ρ1/2,1 =
p2(p1 + 2p0)
{p2(1 − p2)}1/2{(p1 + 2p2)p0 + (p1 + 2p0)p2}1/2
.
Although the null correlations are functions of the unknown parameters pi, i =
0, 1, 2, it can be shown analytically that ρ0,1 < ρ0,1/2 and ρ0,1 < ρ1/2,1. Note
that if the above analytical results were not available, the pi would be estimated
by substituting the observed data pˆi = ni/n for pi. Here the minimum correla-
tion among the three optimal tests occurs when Z0 and Z1 is the extreme pair
for the three genetic models. Freidlin et al. [6] also proved analytically that the
condition (2.4) holds. Hence, ZMERT = (Z0 + Z1)/{2(1 + ρˆ0,1)}
1/2 is the MERT
for the whole family C, where ρˆ0,1 is obtained when the pi are replaced by ni/n.
The two maximum tests can be written as ZMAX2 = max(Z0, Z1) and ZMAX3 =
max(Z0, Z1/2, Z1). When the risk allele is unknown, ZMAX2 = max(|Z0|, |Z1|) and
ZMAX3 = max(|Z0|, |Z1/2|, |Z1|). Although we considered three genetic models, the
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family of genetic models for case-control studies can be extended by defining a ge-
netic model as penetrances restricted to the family {(f0, f1, f2) : f0 ≤ f1 ≤ f2}.
Three genetic models are contained in this family as the two boundaries and one
middle ray of this family. The statistics ZMERT and ZMAX3 are also the correspond-
ing robust statistics for this larger family (see, e.g., Freidlin et al. [6] and Zheng et
al. [26]).
In analysis of case-control data for genetic association, two other tests are also
currently used. However, their robustness and efficiency properties have not been
compared to MERT and MAX. The first one is the chi-squared test for the 2 × 3
contingency table (Table 1), denoted as χ22. (Gibson and Muse [11]) Under the null
hypothesis, it has a chi-squared distribution with 2 df. The second test, denoted as
ZP, is based on the product of two different tests: (a) the allele association (AA)
test and (b) the Hardy-Weinberg disequilibrium (HWD) test. (Hoh, Wile and Ott
[15] and Song and Elston [20]) The AA test is a chi-squares test for the 2× 2 table
given in Table 2, which is written as
χ2AA =
2n[(2r0 + r1)(s1 + 2s2)− (2s0 + s1)(r1 + 2r2)]
2
4rs(2n0 + n1)(n1 + 2n2)
.
The HWD test detects the deviation from Hardy–Weinberg equilibrium (HWE) in
cases. Assume the allele frequency of M is p = Pr(M). Using cases, the estimation
of p is pˆ = (r1 + 2r2)/(2r). Let qˆ = 1 − pˆ be the estimation of allele frequency for
N . Under the null hypothesis of HWE, the expected number of genotypes can be
written as E(NN) = rqˆ2, E(NM) = r2pˆqˆ and E(MM) = rpˆ2, respectively. Hence,
a chi-squared test for HWE is
χ2HWD =
(r0 − E(NN))
2
E(NN)
+
(r1 − E(NM))
2
E(NM)
+
(r2 − E(MM))
2
E(MM)
.
The product test, proposed by Hoh et al. [15], is TP = χ
2
AA
× χ2
HWD
. They noticed
that the power performances of these two statistics are complementary. Thus, the
product should retain reasonable power as one of the tests has high power when the
other does not. Consequently, for a comprehensive comparison, we also consider the
maximum of them, TMAX = max(χ
2
AA
, χ2
HWD
). Given the data, the critical values
of TP and TMAX can be obtained by a permutation procedure as their asymptotic
distributions are not available. (Hoh et al. [15]) Note that TP was originally proposed
by Hoh et al. [15] as a test statistic for multiple gene selection and was modified by
Song and Elston [20] for use as a test statistic for a single gene.
3.3. Power comparison
We conducted a simulation study to compare the power performance of the test
statistics. The test statistics were (a) the optimal trend tests for the three genetic
models, Z0, Z1/2 and Z1, (b) MERT ZMERT, (c) maximum tests ZMAX2 and ZMAX3,
(d) the product test TP, (e) TMAX, and (f) χ
2
2.
In the simulation a two-sided test was used. We assumed that the allele frequency
p and the baseline penetrance f0 are known (f0 = .01). Note that, in practice, the al-
lele frequency and penetrances are unknown. However, they can be estimated empir-
ically (e.g., Song and Elston [20] and Wittke-Thompson, Pluzhnikov and Cox [23]).
In our simulation the critical values for all test statistics are simulated under the null
hypothesis. Thus, we avoid using asymptotic distributions for the test statistics. The
260 G. Zheng, B. Freidlin and J. L. Gastwirth
Type I errors for all tests are expected to be close to the nominal level α = 0.05
and the powers of all tests are comparable. When HWE holds, the probabilities
(p0, p1, p2) for cases and (q0, q1, q2) for controls can be calculated using (3.1) under
the null and alternative hypotheses, where (g0, g1, g2) = (q
2, 2pq, q2) and (f1, f2) are
specified by the null or alternative hypotheses and D =
∑
figi. After calculating
(p0, p1, p2) and (q0, q1, q2) under the null hypothesis, we first simulated the genotype
distributions (r0, r1, r2) ∼ mul(R; p0, p1, p2) and (s0, s1, s2) ∼ mul(S; q0, q1, q2) for
cases and controls, respectively (see Table 1). When HWE does not hold, we as-
sumed a mixture of two populations with two different allele frequencies p1 and p2.
Hence, we simulated two independent samples with different allele frequencies for
cases (and controls) and combined these two samples for cases (and for controls).
Thus, cases (controls) contain samples from a mixture of two populations with dif-
ferent allele frequencies. When p is small, some counts can be zero. Therefore, we
added 1/2 to the count of each genotype in cases and controls in all simulations.
To obtain the critical values, a simulation under the null hypothesis was done
with 200,000 replicates. For each replicate, we calculated the test statistics. For each
test statistic, we used its empirical distribution function based on 200,000 replicates
to calculate the critical value for α = 0.05. The alternatives were chosen so that
the power of the optimal test Z0, Z1/2, Z1 was near 80% for the recessive, additive,
dominant models, respectively. To determine the empirical power, 10,000 replicates
were simulated using multinomial distributions with the above probabilities.
To calculate ZMERT, the correlation ρ0,1 was estimated using the simulated data.
In Table 3, we present the mean of correlation matrix using 10,000 replicates when
r = s = 250. The three correlations ρ0,1/2, ρ0,1, ρ1/2,1 were estimated by replacing
pi with ni/n, i = 0, 1, 2 using the data simulated under the null and alternatives
and various models. The null and alternative hypotheses used in Table 3 were also
used to simulate critical values and powers (Table 4). Note that the minimum
correlation ρ0,1 is less than .50. Hence, the ZMAX3 should have greater efficiency
robustness than ZMERT. However, when the dominant model can be eliminated
based on prior scientific knowledge (e.g. the disease often skips generations), the
correlation between Z0 and Z1/2 optimal for the recessive and additive models would
be greater than .75. Thus, for these two models, ZMERT should have comparable
power to ZMAX2 = max(|Z0|, |Z1/2|) and is easier to use.
The correlation matrices used in Table 4 for r 6= s and Table 5 for mixed sam-
ples are not presented as they did not differ very much from those given in Table 3.
Tables 4 and 5 present simulation results where all three genetic models are plau-
sible. When HWE holds Table 4 shows that the Type I error is indeed close to the
α = 0.05 level. Since the model is not known, the minimum power across three
genetic models is written in bold type. A test with the maximum of the minimum
power among all test statistic has the most power robustness. Our comparison fo-
Table 3
The mean correlation matrices of three optimal test statistics based on 10,000 replicates
when HWE holds
p
.1 .3 .5
Model ρ0,1/2 ρ0,1 ρ1/2,1 ρ0,1/2 ρ0,1 ρ1/2,1 ρ0,1/2 ρ0,1 ρ1/2,1
null .97 .22 .45 .91 .31 .68 .82 .33 .82
rec .95 .34 .63 .89 .36 .74 .81 .37 .84
add .96 .23 .48 .89 .32 .71 .79 .33 .84
dom .97 .21 .44 .90 .29 .69 .79 .30 .83
The same models (rec,add,dom) are used in Table 4 when r = s = 250.
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Table 4
Power comparison when HWE holds in cases and controls under three genetic models
with α = .05
Test statistics
p Model Z0 Z1/2 Z1 ZMERT ZMAX2 ZMAX3 TMAX TP χ
2
2
r = 250, s = 250
.1 null .058 .048 .050 .048 .047 .049 .049 .049 .053
rec .813 .364 .138 .606 .725 .732 .941 .862 .692
add .223 .813 .802 .733 .782 .800 .705 .424 .752
dom .108 .796 .813 .635 .786 .795 .676 .556 .763
.3 null .051 .052 .051 .054 .052 .052 .053 .049 .050
rec .793 .537 .178 .623 .714 .726 .833 .846 .691
add .433 .812 .768 .786 .742 .773 .735 .447 .733
dom .133 .717 .809 .621 .737 .746 .722 .750 .719
.5 null .049 .047 .051 .047 .047 .047 .050 .051 .050
rec .810 .662 .177 .644 .738 .738 .772 .813 .709
add .575 .802 .684 .807 .729 .760 .719 .450 .714
dom .131 .574 .787 .597 .714 .713 .747 .802 .698
r = 50, s = 250
.1 null .035 .052 .049 .052 .051 .053 .045 .051 .052
rec .826 .553 .230 .757 .797 .802 .779 .823 .803
add .250 .859 .842 .773 .784 .795 .718 .423 .789
dom .114 .807 .814 .658 .730 .734 .636 .447 .727
.3 null .048 .048 .048 .048 .050 .050 .050 .048 .049
rec .836 .616 .190 .715 .787 .787 .733 .752 .771
add .507 .844 .794 .821 .786 .813 .789 .500 .778
dom .171 .728 .812 .633 .746 .749 .696 .684 .729
.5 null .049 .046 .046 .046 .047 .047 .046 .049 .046
rec .838 .692 .150 .682 .771 .765 .705 .676 .748
add .615 .818 .697 .820 .744 .780 .743 .493 .728
dom .151 .556 .799 .565 .710 .708 .662 .746 .684
cuses on the test statistics: ZMAX3, TMAX, TP and χ
2
2. Our results show that TMAX
has greater efficiency robustness than TP while ZMAX3, TMAX and χ
2
2 have similar
minimum powers. Notice that ZMAX3 is preferable to χ
2
2 although the difference
in minimum powers depends on the allele frequency. When HWE does not hold,
ZMAX3 still possesses its efficiency robustness, but TMAX and TP do not perform
as well. Thus, population stratification affects their performance. ZMAX3 also re-
mains more robust than χ22 even when HWE does not hold. From both Table 4 and
Table 5, χ22 is more powerful than ZMERT except for the additive model. However,
when the genetic model is known, the corresponding optimal CA trend test is more
powerful than χ22 with 2 df.
From Tables 4 and 5, one sees that the robust test ZMAX3 tends to be more
powerful than χ22 under the various scenarios we simulated. Further comparisons of
these two test statistics using p-values and the same data given in Table 4 (when
r = s = 250) are reported in Table 6. Following Zheng et al. [25], which reported
a matched study, where both tests are applied to the same data, the p-values for
each test are grouped as < .01, (.01, .05), (.05, .10), and > .10. Cross classification
of the p-values are given in Table 6 for allele frequencies p = .1 and .3 under all
three genetic models. Table 6 is consistent with the results of Tables 4 and 5, i.e.,
ZMAX3 is more powerful than the chi-squared test with 2 degrees of freedom when
the genetic model is unknown. This is seen by comparing the counts at the upper
right corner with the counts at lower left corner. When the counts at the upper
right corner are greater than the corresponding counts at the lower left corner,
ZMAX3 usually has smaller p-values than χ
2
2. In particular, we compare two tests
with p-values < .01 versus p-values in (.01, .05). Notice that in most situations
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Table 5
Power comparison when HWE does not hold in cases and controls under three genetic models
(Mixed samples with different allele frequencies (p1, p2) and sample sizes (R1, S1) and (R2, S2)
with r = R1 +R2, s = S1 + S2, and α = .05).
Test statistics
(p1, p2) Model Z0 Z1/2 Z1 ZMERT ZMAX2 ZMAX3 TMAX TP χ
2
2
R1 = 250, S1 = 250 and R2 = 100, S2 = 100
(.1,.4) null .047 .049 .046 .050 .047 .046 .048 .046 .048
rec .805 .519 .135 .641 .747 .744 .936 .868 .723
add .361 .817 .771 .776 .737 .757 .122 .490 .688
dom .098 .715 .805 .586 .723 .724 .049 .097 .681
(.1,.5) null .047 .050 .046 .048 .046 .046 .052 .050 .052
rec .797 .537 .121 .620 .746 .750 .920 .839 .724
add .383 .794 .732 .764 .681 .709 .033 .620 .631
dom .095 .695 .812 .581 .697 .703 .001 .133 .670
(.2,.5) null .048 .052 .052 .054 .052 .052 .050 .047 .050
rec .816 .576 .157 .647 .760 .749 .889 .881 .725
add .417 .802 .754 .782 .726 .743 .265 .365 .684
dom .112 .679 .812 .600 .729 .715 .137 .122 .696
R1 = 30, S1 = 150 and R2 = 20, S2 = 100
(.1,.4) null .046 .048 .048 .046 .048 .046 .055 .045 .048
rec .847 .603 .163 .720 .807 .799 .768 .843 .779
add .387 .798 .762 .749 .725 .746 .449 .309 .691
dom .139 .733 .810 .603 .721 .728 .345 .223 .699
(.1,.5) null .053 .055 .050 .053 .053 .053 .059 .047 .054
rec .816 .603 .139 .688 .776 .780 .697 .827 .741
add .415 .839 .797 .798 .763 .781 .276 .358 .703
dom .120 .726 .845 .612 .750 .752 .149 .133 .716
(.2,.5) null .047 .048 .050 .051 .048 .048 .049 .050 .044
rec .858 .647 .167 .722 .808 .804 .768 .852 .783
add .472 .839 .790 .811 .776 .799 .625 .325 .740
dom .139 .708 .815 .614 .741 .743 .442 .390 .708
the number of times χ22 has a p-value < .01 and ZMAX3 has a p-value in (.01, .05)
is much less than the corresponding number of times when ZMAX3 has a p-value
< .01 and χ22 has a p-value in (.01, .05). For example, when p = .3 and the additive
model holds, there are 289 simulated datasets where χ22 has a p-value in (.01,.05)
while ZMAX3 has a p-value < .01 versus only 14 such datasets when ZMAX3 has
a p-value in (.01,.05) while χ22 has a p-value < .01. The only exception occurs at
the recessive model under which they have similar counts (165 vs. 140). Combining
results from Tables 4 and 6, ZMAX3 is more powerful than χ
2
2, but the difference of
power between ZMAX3 and χ
2
2 is usually less than 5% in the simulation. Hence χ
2
2
is also an efficiency robust test, which is very useful for genome-wide association
studies, where hundreds of thousands of tests are performed.
From prior studies of family pedigrees one may know whether the disease skips
generations or not. If it does, the disease is less likely to follow a pure-dominant
model. Thus, when genetic evidence strongly suggests that the underlying genetic
model is between the recessive and additive inclusive, we compared the performance
of tests ZMERT = (Z0 +Z1/2)/{2(1+ ρˆ0,1/2)}
1/2, ZMAX2 = max(Z0, Z1/2), and χ
2
2.
The results are presented in Table 7. The alternatives used in Table 4 for rec and
add with r = s = 250 were also used to obtain Table 7. For a family with the
recessive and additive models, the minimum correlation is increased compared to
the family with three genetic models (rec, add and dom). For example, from Table 3,
the minimum correlation with the family of three models that ranges from .21 to
.37 is increased to the range of .79 to .97 with only two models. From Table 7,
under the recessive and additive models, while ZMAX2 remains more powerful than
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Table 6
Matched p-value comparison of ZMAX3 and χ
2
2
when HWE holds
in cases and controls under three genetic models
(Sample sizes r = s = 250 and 5,000 replications)
χ2
2
p Model ZMAX3 < .01 .01− .05 .05− .10 > .10
.10 rec < .01 2069 165 0 0
.01− .05 140 1008 251 0
.05− .10 7 52 227 203
> .10 1 25 47 805
add < .01 2658 295 0 0
.01− .05 44 776 212 0
.05− .10 3 23 159 198
> .10 0 5 16 611
dom < .01 2785 214 0 0
.01− .05 80 712 214 0
.05− .10 10 42 130 169
> .10 1 14 27 602
.30 rec < .01 2159 220 0 0
.01− .05 85 880 211 0
.05− .10 6 44 260 157
> .10 2 33 40 903
add < .01 2485 289 0 0
.01− .05 14 849 229 0
.05− .10 1 8 212 215
> .10 0 1 6 691
dom < .01 2291 226 0 0
.01− .05 90 894 204 0
.05− .10 7 52 235 160
> .10 0 26 49 766
Table 7
Power comparison when HWE holds in cases and controls assuming two genetic models
(rec and add) based on 10,000 replicates (r = s = 250 and f0 = .01)
p
.1 .3 .5
Model ZMERT ZMAX2 χ
2
2
ZMERT ZMAX2 χ
2
2
ZMERT ZMAX2 χ
2
2
null .046 .042 .048 .052 .052 .052 .053 .053 .053
rec .738 .729 .703 .743 .732 .687 .768 .766 .702
add .681 .778 .778 .714 .755 .726 .752 .764 .728
other1 .617 .830 .836 .637 .844 .901 .378 .547 .734
other2 .513 .675 .677 .632 .774 .803 .489 .581 .652
other3 .385 .465 .455 .616 .672 .655 .617 .641 .606
other1 is dominant and the other two are semi-dominant, all with f2 = .019.
other 1: f1 = .019. other2: f1 = .017. other3: f1 = .015.
χ22 and ZMERT, the difference in minimum power is much less than in the previous
simulation study (Table 4). Indeed, when studying complex common diseases where
the allele frequency is thought to be fairly high, ZMAX2 and ZMERT have similar
power. Thus, when a genetic model is between the recessive and additive models
inclusive, MAX2 and MERT should be used. In Table 7, some other models were also
included in simulations when we do not have sound genetic knowledge to eliminate
the dominant model. In this case, MAX2 and MERT lose some efficiency compared
to χ22. However, MAX3 still has greater efficiency robustness than other tests. In
particular, MAX3 is more powerful than χ22 (not reported) as in Table 4. Thus,
MAX3 should be used when prior genetic studies do not justify excluding one of
the basic three models.
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4. Discussion
In this article, we review robust procedures for testing hypothesis when the underly-
ing model is unknown. The implementation of these robust procedures is illustrated
by applying them to testing genetic association in case-control studies. Simulation
studies demonstrated the usefulness of these robust procedures when the underlying
genetic model is unknown.
When the genetic model is known (e.g., recessive, dominant or additive model),
the optimal Cochran-Armitage trend test with the appropriate choice of x is more
powerful than the chi-squared test with 2 df for testing an association. The genetic
model is usually not known for complex diseases. In this situation, the maximum of
three optimal tests (including the two extreme tests), ZMAX3, is shown to be efficient
robust compared to other available tests. In particular, ZMAX3 is slightly more
powerful than the chi-squared test with 2 df. Based on prior scientific knowledge,
if the dominant model can be eliminated, then MERT, the maximum test, and the
chi-squared test have roughly comparable power for a genetic model that ranges
from recessive model to additive model and the allele frequency is not small. In this
situation, the MERT and the chi-squared test are easier to apply than the maximum
test and can be used by researchers. Otherwise, with current computational tools,
ZMAX3 is recommended.
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